|Assessment Status||Rapid Review Complete|
|Indication||Pitolisant hydrochloride (Wakix®) is indicated in adults, adolescents, and children aged 6 years and older for the treatment of narcolepsy with or without cataplexy|
|Rapid review commissioned||30/08/2023|
|Rapid review resubmission required||12/09/2023|
|Rapid review completed||04/10/2023|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that pitolisant hydrochloride (Wakix®) for adolescents and children aged 6 years and older not be considered for reimbursement at the submitted price*.|
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.